The University of Michigan has been selected as one of the Clinical Centers (CC) for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network (U01). This network represents the extension of the ARDS Clinical Network developed to perform multi-site clinical trials in patients with ARDS. The University of Michigan is one of twelve clinical sites throughout the country, and will be led by Robert Hyzy, M.D. from the Division of Pulmonary and Critical Care Medicine. Other key investigators include Theodore Standiford, M.D. (Division of Pulmonary and Critical Care Medicine), Pauline Park, M.D. (Department of Surgery), and Kyle Gunnerson, M.D. (Department of Emergency Medicine).
June 6, 2014
Kyle Gunnerson, M.D. named as one of the key investigators in Clinical Centers for the NHLBI Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network.